-
Safety
Femara (letrozole) 2.5 mg tablets
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) -- July 2009
ADVERSE REACTIONS
Post-Marketing Experiences
-
-

